CA
NZ
UK
AU
IND
US
The company's shares closed at USD 22.51, representing a +1.17% gain, in response to the announcement. This uptick reflects investors' confidence in Pacira Biosciences Inc'sLong-term Growthprospects.
Shareholders of Power Integrations Inc. (NASDAQ: POWI) have ratified all board proposals at the company'sAnnual General Meeting(AGM). The AGM covered key elections, executive compensation, and an incentive plan amendment, which were all approved unanimously. However, a shareholder proposal for an independent board chairman was …
QuidelOrtho Corporation (NASDAQ: QDEL), a leading health care company, is poised for growth driven by significant cost savings, new product launches, and regional recoveries. The company's efforts to optimize its operations have set the stage forMarginexpansion and renewed growth in the second half.
Shake Shack Inc (SHAK) (NYSE: SHAK) is facing a possible securities law investigation after the company significantly reduced its FY 2026 revenue guidance on June 2, 2026. The New York-based burger chain cut its earnings estimates, citing macroeconomic uncertainty, competitive landscape, and rising beef …
Simpson Manufacturing Co., Inc. (NYSE: SSD), an industry leader in engineered structural connectors and building solutions, has announced its participation in the upcoming Wells Fargo 16th Annual Industrials & Materials Conference. The company's Chief Executive Officer, Mike Olosky, and Chief Financial Officer, Matt Dunn, …
In the latest development, Sintx Technologies Inc. (NASDAQ: SINT) has completed a recent equity raise of approximately $5 million through a series of at-the-market offering programs and a concurrent public offering.
MGM Resorts International (NYSE: MGM) has been downgraded by CBRE to Hold from Buy, as part of a broader assessment of the company's position in the Hotels, Restaurants & Leisure sector. The analyst's move comes after a thorough evaluation of MGM's recent performance and …
Shares of Mineralys Therapeutics Inc. (NASDAQ: MLYS) have declined following the company's recent $150M offering. This decline in share price is not uncommon after a large-scaleCapitalraise, where investors may reassess their valuation expectations.
On the news, NRX Pharmaceuticals shares have moved lower in value. The company's stock price is down compared to its previous session highs.
In another market, assets in leveraged U.S. equity ETFs have doubled in two months. By the end of May, these investments totalled $84 billion, up from $39 billion in April. Additionally, leveraged ETFs on South Korea and Taiwan surged to $43.1 billion from $17 …
Please wait processing your request...